CSO Exam 2026 MOST Recent
Tested,Actual Exam Questions (2026)
WITH Recent Newest Verified And Well
Analyzed Exam Questions (Actual Exam
2026-2027) Correct Detailed & Verified
ANSWERS (100% Accurate Solutions)
ALREADY GRADED A+|| NEWEST
VERSION Of The Exam Guarantee Pass!!
List some risk factors for anticipatory nausea and vomiting - ANSWERS-1. Age younger
than 50 years.
2. N&V after the last chemotherapy session.
3. Post-treatment nausea OR vomiting described as moderate, severe, or intolerable.
4. Susceptibility to motion sickness.
5. Female gender.
6. High-state anxiety
7. Patient expectations of chemotherapy-related nausea before beginning treatment.
8. Emetogenic potential of various chemotherapeutic agents. Patients receiving drugs
with a moderate to severe potential for post-treatment N&V are more likely to develop
ANV.
9. History of morning sickness during pregnancy.
A cancer patient is unable to provide self-care. His disease is progressing rapidly and
prognosis is poor. Which number likely represents his Karnofsky Performance Status?
A. 100
B. 70
,C. 40
D. 0 - ANSWERS-C. 40
Disabled; requires special care & assistance.
There are many different herbal supplements that affect CYP3A enzymes, including
these 5 supplements: - ANSWERS-•St John's Wort
•Black cohosh
•Ginseng
•Ginko biloba
•Goldenseal
Which chemotherapy drug is known to cause Pharyngolaryngeal dysesthesia? -
ANSWERS-Oxaliplatin (Eloxatin)
This medication has an unusual side effect called "cold dysesthesia". - ANSWERS-
Oxaliplatin (Trade Name: Eloxatin)
What can a cancer patient do to reduce the likelihood of experiencing cold dysesthesia
while receiving treatment with Oxaliplatin? - ANSWERS-•Do not drink cold drinks or use
ice cubes in drinks.
•Do not put ice or ice packs on your body.
•Do not take things from the freezer or refrigerator without wearing gloves.
•Drink fluids warm or at room temperature.
•Always drink through a straw.
•Do not use ice chips if you have nausea or a sore mouth.
A patient with newly diagnosed pancreatic cancer completes the Scored Patient-
Generated Subjective Global Assessment (PG-SGA©) with information regarding
weight, food intake, symptoms and activities/functional status. The additive score is 10.
What does this score mean?
A. No intervention is required at this time.
, B. Requires intervention by RD with RN or MD
C. Indicates a critical need for improved symptom management &/or nutrient
intervention options - ANSWERS- C >/= 9 Indicates a critical need for improved
symptom management &/or nutrient intervention options
TRUE or FALSE The antiemetic Ondansetron (Zofran) may cause constipation or
diarrhea in cancer patients - ANSWERS-TRUE
•Constipation -- in up to 9% of patients
•Diarrhea -- in up to 7 % of patients
Anticipatory nausea and vomiting (ANV) - ANSWERS-Anticipatory nausea and vomiting
(ANV), also is widely believed to be a learned response to chemotherapy that 25% of
patients develop by the 4th treatment cycle
The American Society of Clinical Oncology (ASCO) provides a summary of IV
chemotherapeutic agents and their respective risk of acute and delayed emesis.
•High risk: Emesis that has been documented to occur in more than 90% of patients: -
ANSWERS-•Anthracycline/cyclophosphamide combination.
•Carmustine (BiCNU®)
•Cisplatin (Platinol®)
•Cyclophosphamide (Cytoxan) (≥1,500 mg/m2).
•Dacarbazine
•Dactinomycin.
•Mechlorethamine (Mustargen®)
•Streptozotocin (Zanosar®)
Streptozotocin (Zanosar®) alters __________________________ metabolism in some
patients causing ________________________ - ANSWERS-Streptozotocin (Zanosar®)
alters glucose metabolism in some patients causing hypoglycemia
A cancer patient is fully active and able to carry on all pre-disease activities without
restrictions. Which Eastern Cooperative Oncology Group (ECOG) grade is appropriate?
A. Grade 0
Tested,Actual Exam Questions (2026)
WITH Recent Newest Verified And Well
Analyzed Exam Questions (Actual Exam
2026-2027) Correct Detailed & Verified
ANSWERS (100% Accurate Solutions)
ALREADY GRADED A+|| NEWEST
VERSION Of The Exam Guarantee Pass!!
List some risk factors for anticipatory nausea and vomiting - ANSWERS-1. Age younger
than 50 years.
2. N&V after the last chemotherapy session.
3. Post-treatment nausea OR vomiting described as moderate, severe, or intolerable.
4. Susceptibility to motion sickness.
5. Female gender.
6. High-state anxiety
7. Patient expectations of chemotherapy-related nausea before beginning treatment.
8. Emetogenic potential of various chemotherapeutic agents. Patients receiving drugs
with a moderate to severe potential for post-treatment N&V are more likely to develop
ANV.
9. History of morning sickness during pregnancy.
A cancer patient is unable to provide self-care. His disease is progressing rapidly and
prognosis is poor. Which number likely represents his Karnofsky Performance Status?
A. 100
B. 70
,C. 40
D. 0 - ANSWERS-C. 40
Disabled; requires special care & assistance.
There are many different herbal supplements that affect CYP3A enzymes, including
these 5 supplements: - ANSWERS-•St John's Wort
•Black cohosh
•Ginseng
•Ginko biloba
•Goldenseal
Which chemotherapy drug is known to cause Pharyngolaryngeal dysesthesia? -
ANSWERS-Oxaliplatin (Eloxatin)
This medication has an unusual side effect called "cold dysesthesia". - ANSWERS-
Oxaliplatin (Trade Name: Eloxatin)
What can a cancer patient do to reduce the likelihood of experiencing cold dysesthesia
while receiving treatment with Oxaliplatin? - ANSWERS-•Do not drink cold drinks or use
ice cubes in drinks.
•Do not put ice or ice packs on your body.
•Do not take things from the freezer or refrigerator without wearing gloves.
•Drink fluids warm or at room temperature.
•Always drink through a straw.
•Do not use ice chips if you have nausea or a sore mouth.
A patient with newly diagnosed pancreatic cancer completes the Scored Patient-
Generated Subjective Global Assessment (PG-SGA©) with information regarding
weight, food intake, symptoms and activities/functional status. The additive score is 10.
What does this score mean?
A. No intervention is required at this time.
, B. Requires intervention by RD with RN or MD
C. Indicates a critical need for improved symptom management &/or nutrient
intervention options - ANSWERS- C >/= 9 Indicates a critical need for improved
symptom management &/or nutrient intervention options
TRUE or FALSE The antiemetic Ondansetron (Zofran) may cause constipation or
diarrhea in cancer patients - ANSWERS-TRUE
•Constipation -- in up to 9% of patients
•Diarrhea -- in up to 7 % of patients
Anticipatory nausea and vomiting (ANV) - ANSWERS-Anticipatory nausea and vomiting
(ANV), also is widely believed to be a learned response to chemotherapy that 25% of
patients develop by the 4th treatment cycle
The American Society of Clinical Oncology (ASCO) provides a summary of IV
chemotherapeutic agents and their respective risk of acute and delayed emesis.
•High risk: Emesis that has been documented to occur in more than 90% of patients: -
ANSWERS-•Anthracycline/cyclophosphamide combination.
•Carmustine (BiCNU®)
•Cisplatin (Platinol®)
•Cyclophosphamide (Cytoxan) (≥1,500 mg/m2).
•Dacarbazine
•Dactinomycin.
•Mechlorethamine (Mustargen®)
•Streptozotocin (Zanosar®)
Streptozotocin (Zanosar®) alters __________________________ metabolism in some
patients causing ________________________ - ANSWERS-Streptozotocin (Zanosar®)
alters glucose metabolism in some patients causing hypoglycemia
A cancer patient is fully active and able to carry on all pre-disease activities without
restrictions. Which Eastern Cooperative Oncology Group (ECOG) grade is appropriate?
A. Grade 0
